Journal profile · Engineering-Biomedical Engineering
Regenerative Therapy
ISSN 2352-3204 · Japanese Society of Regenerative Medicine · NETHERLANDS
Regenerative Therapy: CAS Zone 3 · Medicine (2025 upgraded edition); impact factor 3.96; fully open access; APC about USD 1,800; median 88 days to acceptance (103 articles, last 24 months); 221 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Regenerative Therapy is published by Japanese Society of Regenerative Medicine and is in Zone 3 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Mesenchymal stem cell research, Tissue Engineering and Regenerative Medicine and Pluripotent Stem Cells Research, together about 36.6% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
Peer review under the responsibility of the Japanese Society for Regenerative Medicine.Regenerative Therapy is the official peer-reviewed online journal of the Japanese Society for Regenerative Medicine.Regenerative Therapy is a multidisciplinary journal that publishes original articles and reviews of basic research, clinical translation, industrial development, and regulatory issues focusing on stem cell biology, tissue engineering, gene therapy, and regenerative medicine.
From the journal's Aims & Scope
Research area (LetPub): Engineering-Biomedical Engineering
Editor-in-chief Ung-il ChungPublisher website
Editorial board by country: none in mainland China; most named United States 11, Japan 10, Germany 4, South Korea 2, Sweden 2 (34 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Mesenchymal stem cell researchMedicine17.3%
- Tissue Engineering and Regenerative MedicineMedicine10.5%
- Pluripotent Stem Cells ResearchBiochemistry, Genetics and Molecular Biology8.7%
- Periodontal Regeneration and TreatmentsMedicine6.7%
- Wound Healing and TreatmentsMedicine6%
- 3D Printing in Biomedical ResearchEngineering5.6%
- Osteoarthritis Treatment and MechanismsMedicine5.4%
- Extracellular vesicles in diseaseBiochemistry, Genetics and Molecular Biology4.1%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Cell & Tissue Engineering | Zone 3 |
| Minor | Engineering, Biomedical | Zone 3 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Cell & Tissue Engineering | Zone 3 |
| Minor | Engineering, Biomedical | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Environmental Science & Ecology Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Environmental Science & Ecology | Zone 3 |
| Minor | Engineering, Biomedical | Zone 3 |
| Minor | Cell & Tissue Engineering | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 3.96LetPub ·
- Impact factor (publisher)
- 4Publisher website ·
- CiteScore 2026-06
- 5.3LetPub ·
- CiteScore (publisher)
- 5.3Publisher website ·
- SJR 2026-06
- 0.84LetPub ·
- SNIP 2026-06
- 0.88LetPub ·
- h-index
- 8LetPub ·
- h-index
- 49OpenAlex ·
- i10-index
- 456OpenAlex ·
- 2-year mean citedness
- 5.25OpenAlex ·
- Self-citation rate
- 5%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 211LetPub ·
Articles by year OpenAlex count · 1,167 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 103 | 103 | 31 |
| 2025 | 221 | 221 | 1,095 |
| 2024 | 216 | 216 | 1,711 |
| 2023 | 126 | 126 | 1,524 |
| 2022 | 115 | 115 | 1,679 |
| 2021 | 82 | 82 | 2,063 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
88 daysMedian, submission to acceptance · P25–P75 69 days – 113 days
- Acceptance to online
- median 7 days (103 articles)
- Submission to online
- median 94 days
- Sample
- 103 articles with submission and acceptance dates (418 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 25 weeksLetPub ·
- First decision after review
- 27 daysPublisher website ·
- Submission to acceptance
- 71 daysPublisher website ·
- Submission to publication (journal-reported)
- about 12 weeksDOAJ ·
- Peer review
- Double anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | USD 1,800 | Yes | CC BY-NC-ND | |
| OpenAlex | USD 1,800 / EUR 1,680 / GBP 1,440 / JPY 223,250 | — | — | |
| LetPub | USD 1,100 | Yes | — | |
| Publisher website | USD 1,800 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare3 items from the author guidelines
- Keywords
- 3–6
- Reference style
- Numbered, in order of citation
- Graphical abstract
- Optional
Article types accepted9
- commentariesContributions falling into the following categories will be considered for publication: Original articles, Review articles, Reports, Commentaries, and Letters t…Length not stated
- commentaryContributions falling into the following categories will be considered for publication: Original articles, Review articles, Reports, Commentaries, and Letters t…Length not stated
- editorialsEditorials: Editorials are considered for publication by invitation.Length not stated
- letters to the editorContributions falling into the following categories will be considered for publication: Original articles, Review articles, Reports, Commentaries, and Letters t…Length not stated
- original articleContributions falling into the following categories will be considered for publication: Original articles, Review articles, Reports, Commentaries, and Letters t…Length not stated
- original articlesContributions falling into the following categories will be considered for publication: Original articles, Review articles, Reports, Commentaries, and Letters t…Length not stated
- reportsContributions falling into the following categories will be considered for publication: Original articles, Review articles, Reports, Commentaries, and Letters t…Length not stated
- review articleContributions falling into the following categories will be considered for publication: Original articles, Review articles, Reports, Commentaries, and Letters t…Length not stated
- review articlesContributions falling into the following categories will be considered for publication: Original articles, Review articles, Reports, Commentaries, and Letters t…Length not stated
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, License & copyright, Open access, Peer review, Preprints
- AI use Declaration of generative AI in scientific writing
Authors must declare the use of generative AI tools in the manuscript preparation process upon submission of the paper.Generative AI and AI-assisted technologies (“AI tools”) have been rapidly adopted in research and scholarly publishing, offering significant benefits while requiring clear standards for responsible and transparent use.Authors preparing a manuscript for this journal may use AI tool…
Source ↗Publisher website ·- Authorship Changes to authorship
Authors are expected to consider carefully the list and order of authors before submitting their manuscript and provide the definitive list of authors at the time of the original submission. Any addition, deletion or rearrangement of author names in the authorship list should be made only before the manuscript has been accepted and only if approved by the journal Editor. To request such a change, …
Source ↗Publisher website ·- Conflicts of interest Declaration of interest
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence (bias) their work. Examples of potential competing interests include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding. Authors must disclose any interests in two places:…
Source ↗Publisher website ·- License & copyright Copyright
Upon acceptance of an article, authors will be asked to complete a 'Journal Publishing Agreement' (for more information on this and copyright, see https://www.elsevier.com/copyright). An e-mail will be sent to the corresponding author confirming receipt of the manuscript together with a 'Journal Publishing Agreement' form or a link to the online version of this agreement.Author rightsAs an author …
Source ↗Publisher website ·- Open access Open access
Please visit our Open Access page for more information about open access publishing in this journal.
Source ↗Publisher website ·- Peer review Peer review
This journal operates a single anonymized review process. All contributions are typically sent to a minimum of two independent expert reviewers to assess the scientific quality of the paper. The Editor is responsible for the final decision regarding acceptance or rejection of articles. The Editor's decision is final. Editors are not involved in decisions about papers which they have written themse…
Source ↗Publisher website ·- Preprints Preprint references
Where a preprint has subsequently become available as a peer-reviewed publication, the formal publication should be used as the reference. If there are preprints that are central to your work or that cover crucial developments in the topic, but are not yet formally published, these may be referenced. Preprints should be clearly marked as such, for example by including the word preprint, or the nam…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Japanese Society of Regenerative Medicine
- Country or region
- NETHERLANDS
- Language
- English
- ISSN
- 2352-3204
- Official links
- Journal homepage ↗DOAJ
- Submission system ↗Publisher website
- Author guidelines ↗DOAJ
- Aims & Scope ↗DOAJ
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗DOAJ
- Editorial board ↗DOAJ
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Regenerative Therapy
What CAS zone is Regenerative Therapy in?
In the 2025 upgraded edition of the CAS Journal Ranking, Regenerative Therapy is in Zone 3 of Medicine, and in Zone 3 of the minor category Cell & Tissue Engineering / Engineering, Biomedical. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Regenerative Therapy?
The latest impact factor listed by LetPub is 3.96; CiteScore 5.3, h-index 49.
How long does peer review take at Regenerative Therapy?
Based on the dates recorded on 103 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 88 days (interquartile range 69–113 days); authors report an average review time of about 25 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Regenerative Therapy?
According to the journal's author guidelines: Keywords: 3–6; Reference style: Numbered, in order of citation; Graphical abstract: Optional. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Regenerative Therapy based?
Of the 34 board members whose country the journal's board page names, none are in mainland China; the countries named most often are United States (11), Japan (10) and Germany (4). Counted from the institutions listed on the board page; for reference only.
Which databases index Regenerative Therapy?
According to LetPub and DOAJ records, Regenerative Therapy is indexed in SCIE, Scopus and DOAJ.
Is Regenerative Therapy open access, and what is the APC?
Regenerative Therapy is a fully open-access journal. APC about USD 1,800.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .